Cite
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity.
MLA
Kremer, Andreas E., et al. “Successful Treatment of COVID‐19 Infection with Convalescent Plasma in B‐cell‐depleted Patients May Promote Cellular Immunity.” European Journal of Immunology, vol. 51, no. 10, Oct. 2021, pp. 2478–84. EBSCOhost, https://doi.org/10.1002/eji.202149277.
APA
Kremer, A. E., Kremer, A. N., Willam, C., Völkl, S., Verhagen, J., Achenbach, S., van der Meijden, E. D., Lang, V., Aigner, M., Maier, C., Tenbusch, M., Korn, K., Lutzny, G. G., Spoerl, S., Strauß, R., Vetter, M., Überla, K., Neurath, M. F., Mackensen, A., & Schiffer, M. (2021). Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity. European Journal of Immunology, 51(10), 2478–2484. https://doi.org/10.1002/eji.202149277
Chicago
Kremer, Andreas E., Anita N. Kremer, Carsten Willam, Simon Völkl, Johan Verhagen, Susanne Achenbach, Edith D. van der Meijden, et al. 2021. “Successful Treatment of COVID‐19 Infection with Convalescent Plasma in B‐cell‐depleted Patients May Promote Cellular Immunity.” European Journal of Immunology 51 (10): 2478–84. doi:10.1002/eji.202149277.